Physician profile
Morgan Jackson
NPI 1073075453
$4,580.76
in general payments reported to CMS, 2019-2025
34 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $878 · 2022: $1,037 · 2023: $729 · 2024: $792 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,601 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,600.52 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,010.99 | 2021-2025 | |
| Incyte Corporation | $353.53 | 2023-2025 | Opzelura, Opzelura |
| Novartis Pharmaceuticals Corporation | $311.90 | 2023-2025 | |
| Pfizer INC. | $307.79 | 2022-2025 | |
| Genzyme Corporation | $303.73 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $237.09 | 2022 | |
| Janssen Scientific Affairs, LLC | $184.03 | 2022 | |
| Ucb, INC. | $175.01 | 2024-2025 | Bimzelx |
| Leo Pharma INC. | $174.29 | 2025 | Anzupgo, Adbry |
| Collegium Pharmaceutical, INC. | $156.97 | 2021 | |
| Sun Pharmaceutical Industries INC. | $143.14 | 2023-2025 | Ilumya, Winlevi, Absorica Ld |
| Amgen INC. | $126.93 | 2021-2022 | |
| Horizon Therapeutics Plc | $115.67 | 2021-2022 | |
| Nevro Corp. | $104.50 | 2021-2022 | |
| Galderma Laboratories, L.P. | $94.07 | 2024-2025 | Nemluvio |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $92.45 | 2024 | Sotyktu |
| Biohaven Pharmaceuticals, INC. | $83.39 | 2021 | |
| Grt US Holding, INC. | $71.67 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $71.46 | 2021 | |
| Arcutis Biotherapeutics, INC. | $62.84 | 2024 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $59.94 | 2023 | Siliq |
| Scilex Pharmaceuticals INC. | $59.19 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.84 | 2022 | |
| Allergan, INC. | $34.29 | 2021-2022 | |
| Uswm, LLC | $32.70 | 2021-2022 | |
| Si-Bone, INC. | $31.35 | 2021 | |
| Ibsa Pharma INC. | $22.58 | 2021 | |
| Merz Pharmaceuticals, LLC | $20.70 | 2021 | |
| Lundbeck LLC | $19.00 | 2022 | |
| Lilly USA, LLC | $17.56 | 2025 | Ebglyss |
| Verrica Pharmaceuticals INC. | $14.24 | 2025 | Ycanth |
| Bioventus LLC | $13.35 | 2021 | |
| Medtronic, INC. | $11.36 | 2021 | |
| Metacel Pharmaceuticals LLC | $10.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.